Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
NIH - National Institutes of Health (PAR-19-368)
- Proposal: 02/05/2020
- Amount: Up to $499,999 per year
- Duration: Up to 5 years
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco, prescription and other substances) and related disorders, prevention of substance use and HIV, and health service utilization.
This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of substance using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of substance use disorder and HIV.
The NIDA and NIAAA are particularly interested in innovative analyses of extant data, including new aims that are being addressed with existing data, new or advanced methods of analyses, or novel combination and integration of datasets to allow the exploration of new questions.
Strongly encouraged is the application of innovative methods or techniques from other disciplines that are novel to substance use and disorder research, such as utilization of systems science methodologies (e.g., agent based modeling, system dynamics modeling, network analysis) or geographic information systems (GIS). Use of multiple sources of data towards predicting substance use behaviors and solutions is also encouraged
Marsha F. Lopez, Ph.D., M.H.S
National Institute on Drug Abuse (NIDA)
I-Jen Castle, PhD
National Institute on Alcohol Abuse and Alcoholism (NIAAA)